Targets to Therapies: Mitochondrial Target Validation supports researchers studying mitochondrial targets to build evidence that guides therapeutic decisions for Parkinson’s disease.
Parkinson's Disease Biomarker Innovation and Advancement Program supports teams developing fluid- and imaging-based biomarkers for clinical implementation and broader use in Parkinson's research.
The Parkinson's Foundation Impact Awards fund bold research to advance understanding of Parkinson’s disease biology or accelerate new interventions.
NIH supports phased research to identify and validate modifiable mechanisms and therapeutic targets for central nervous system complications in people with HIV; clinical trials are not allowed.
In-vitro models & assays to identify novel therapies for neuroinflammatory diseases supports researchers developing human-centered models and assays to discover and optimize small-molecule treatments.
Principal Investigator Award – UMDF 2026 Research Grant Program supports independent investigators' research to improve diagnosis, develop treatments, and pursue cures for primary mitochondrial disease.